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Lyme neuroborreliosis or “neurological Lyme disease” was evidenced in 2 of 23 patients submitted to strict criteria for case
selection of the Centers for Disease Control and Prevention employing a two-tier test to detect antibodies to Borrelia burgdorferi at
a single institution. One patient had symptomatic polyradiculoneuritis, dysautonomia, and serological evidence of early infection;
and another had symptomatic small ﬁber sensory neuropathy, distal polyneuropathy, dysautonomia, and serological evidence of
late infection. In the remaining patients symptoms initially ascribed to Lyme disease were probably unrelated to B. burgdorferi
infection. Our ﬁndings suggest early susceptibility and protracted involvement of the nervous system most likely due to the
immunological eﬀects of B. burgdorferi infection, although the exact mechanisms remain uncertain.
1.Introduction
Lyme disease is a multisystem infectious disease caused by
the bite of the hard shelled Ixodes tick-borne spirochete
B. burgdorferi sensu stricto (hereafter referred to as B.
burgdorferi), which frequently aﬀects the nervous system [1].
Heightened awareness of the spectrum of Lyme neurobor-
reliosis (LNB) has resulted in increased serological testing
to detect antibodies to B. burgdorferi in patients with early
and late infection, and in many, even without the typical
clinical features, who may nonetheless be receiving empiric
antibiotics for late disease [2]. With this in mind the ﬁrst
50 patients with presumed LNB were screened and strict
criteria were applied for case ascertainment of Lyme disease.
Two patients with varying involvement of the central (CNS),
peripheral(PNS),andautonomicnervoussystem(ANS)and
varied duration of LNB emerged. A preliminary report has
been published [3].
2. Methods
The records of 50 consecutive patients referred to the author
(D.S.Y.) were selected for inclusion based upon conformity
to strict criteria for clinical and laboratory case deﬁnition
of Lyme disease of the Centers for Disease Control and
Prevention (CDC) [4, 5]. The majority of patients were
referred with the diagnosis of chronic Lyme disease [6]a n d
had received, or were receiving, antibiotic therapy for per-
sistent Borrelia burgdorferi infection. Altogether, 23 patients
underwent two-tier serological testing for the diagnosis of
Lyme disease at the single reference laboratory, Stony Brook
University Laboratory, New York, employing a ﬁrst-tier
screeningenzyme-linkedimmunoassay(ELISA)andsecond-
tier IgG and IgM immunoblots performed on reactive or
borderline results as recommended by the CDC [5]. The
27 patients that had laboratory studies for Lyme disease
performed elsewhere were excluded from this analysis. Of
the remaining 21 patients, 5 with nonreactive ﬁrst-tier
ELISA as well as 12 with reactive and 4 with borderline
reactive screening serology, all with nonconﬁrmatory Lyme
IgG or IgM immunoblots, were also excluded. Two patients
described below met criteria for case selection.
Noncontrast magnetic resonance imaging (MRI) and
nuclear medicine (NM) cerebral perfusion imaging with
single-photon emission spectroscopy (SPECT) screened for2 Neurology Research International
brain dysfunction, the main symptoms of which were
typically neurocognitive.
Quantitative sensory testing (QST) for heat pain per-
ception thresholds [7] and epidermal nerve ﬁber (ENF)
studies of the thigh and calf [8] screened for small ﬁber
sensory nerve (SFSN) dysfunction [9], the main symptom of
which was dysesthesia, often reported as tingling, prickling,
burning, deep aching, jabbing, or shooting sensations often
in association with numbness and coldness of the limbs.
Quantitative sudomotor axon reﬂex testing, beat-to-beat
blood pressure (BP), and heart rate responses to head-up
tilt, deep breathing, Valsalva maneuver, with calculation of
a composite autonomic scoring scale (CASS) using a WR
Electronics laboratory, Rochester, Minnesota, [10]s c r e e n e d
for ANS dysfunction, the symptoms of which consisted of
postural hypotension, palpitation, dizziness, headache, and
lightheadedness.
Electrodiagnostic studies including nerve conductions
and electromyography of the arms and legs deﬁned PNS
dysfunction including distal polyneuropathy (DPN) [11]
and polyradiculoneuritis [12] in the two patients, the
symptoms of which included patchy radicular peripheral
nervedisturbancesoftenwithlittleornomotorinvolvement.
Cerebrospinal ﬂuid (CSF) was not collected for diag-
nostic levels of IgM and IgG antibodies alone or in paired
analysis with serum, or for isolation of B. burgdorferi using
polymerase chain reaction studies, in either patient, and thus
was not available for retrospective analysis.
3. PatientDescriptions
3.1. Patient 1. A previously normal 38 year old woman
had lightheadedness, dizziness, palpitation, and headache
commencing 3 months after tick bite, fever, joint pain,
and erythema migrans (EM) rash in the summer of 2007
that prompted the clinical diagnosis of Lyme disease.
Neurological examination showed slight tandem imbalance,
stocking cold temperature, and vibratory sensory loss with
otherwise normal cognition, cranial nerves, limb strength,
coordination, and reﬂexes. Laboratory testing showed reac-
tive Lyme serology with an optical density (OD) of .263
(reactive cutoﬀ + 3 standard deviations (SD) .130), positive
IgM immunoblot comprised of 23 and 41kDa bands, and a
negative IgG immunoblot. Noncontrast brain MRI showed
a few punctuate scattered supratentorial white matter sig-
nal abnormalities. Cerebral perfusion with SPECT showed
mildly diminished blood ﬂow in the posterior temporal and
parietal lobes. Electrodiagnostic studies of the left arm and
legs showed patchy polyradiculoneuritis. Epidermal nerve
ﬁber studies and QST of the left hand and foot were normal.
Autonomic studies showed exaggerated postural tachycardia
on active stand and tilting for 10 minutes, with abnormal
fall in BP during phase II of the Valsalva maneuver with
an overall CASS of 1. She was treated with oral doxycycline
100mg bid for one month with steady mild subjective
improvement that was sustained over the ensuing three
months although repeat electrodiagnostic and autonomic
neurophysiological testing were not performed.
3.2. Patient 2. Ap r e v i o u s l yn o r m a l4 8y e a ro l dw o m a nw a s
diagnosed with Lyme disease following a tick bite and EM
rashandtreatedwithoralfollowedbyintravenousantibiotics
according to prevailing standards [13]. One year later
she noted cognitive impairment, imbalance, and sensory
disturbanceinthelegs.Lymeserologicalstudieswerereactive
withanODof1.201(reactivecutoﬀ .149),positiveLymeIgG
immunoblot comprised of 18, 28, 30, 41, 45, 58, and 93kDa
bands, and negative IgM immunoblot. Neurological exami-
nation showed mild stocking vibratory and cold temperature
sensorylosswithotherwisenormalcognition,cranialnerves,
limb strength, coordination, and reﬂexes. Electrodiagnostic
studies including EMG/NCS showed a distal sensorimotor
neuropathy with mixed demyelinating and axonal features.
Neuropsychological studies revealed signiﬁcant deﬁcits in
semantic ﬂuency, reading speed and comprehension, audi-
tory attention, visual and verbal memory, psychomotor
speed, and phonemic verbal ﬂuency, without depression or
anxiety. Noncontrast brain MRI was normal. Quantitative
sensory testing showed heat pain thresholds below the 5th
percentile in the left foot and normal in the left hand. Cere-
bral perfusion with SPECT showed decreased perfusion in
thetemporallobes.AutonomictestingshowedmildphaseIV
attenuation of the Valsalva maneuver with an overall CASS
of 1. She was not treated with further antibiotics. Sustained
subjectiveandobjectiveneurologicalimprovementonrepeat
examination 3 months later paralleled improvement on
repeat autonomic neurophysiological studies and QST after
an empiric course of 2 grams per kilogram of intravenous
immunoglobulin (IVIg) in 5 successive days per month for 3
months for acquiredautoimmune peripheral and autonomic
neuropathy.
4. Discussion
Twopatients met CDC criteria for the clinical and laboratory
diagnosis of Lyme disease, including one with symptomatic
polyradiculoneuritis, dysautonomia, and serological evi-
dence of early infection and the other with SFSN, DPN,
dysautonomia,andserologicalevidenceoflateinfection.The
remaining 21 patients had negative or indeterminate labo-
ratory evidence of Lyme disease indicating that symptoms
initially ascribed to Lyme disease were probably unrelated to
B. burgdorferi infection. The CDC [4, 5] has not determined
the sensitivity or speciﬁty of the serological diagnosis of
Lyme disease in any given cohort, using diagnostic levels of
IgM and IgG antibodies to the B. burgdorferi spirochete in
serum. Thus, it is uncertain whether having 2 of 23 patients
(8.7%) with diagnostic serology for Lyme disease in a given
cohort with primarily chronic symptoms is representative of
our cohort. A two-tier test approach for active disease and
previous infection with the demonstration of a signiﬁcant
change in IgM or IgG antibody response to B. burgdorferi
in paired acute- and convalescent-phase serum samples,
examination of diagnostic levels of IgM and IgG antibodies
to the spirochete in CSF, and isolation of B. burgdorferi from
CSF are recommended to improve the diagnostic accuracy of
serological testing in Lyme disease [4, 5], including LNB.Neurology Research International 3
Unlike meningitis, cranial neuritis, polyradiculoneuritis
[14], and encephalomyelitis [15] which have been ascribed
to the direct eﬀects of B. burgdorferi infection, the etiopatho-
genesis of encephalopathy, SFSN, DPN, and dysautono-
mia are less certain, and probably related to autoimmune
factors, triggered by exposure to B. burgdorferi antigens.
Two candidate antigens that cross-react with constituent
peripheral nerve molecules, one against ﬂagellin and the
other against gangliosides experimentally, are found in the
sera and peripheral nerve of aﬀected patients [16–18].
Acquired autonomic neuropathy, in which autonomic ﬁbers
are selectively or disproportionately aﬀected, is presumably
also of autoimmune cause as suggested by the occurrence
of autonomic neuropathy after Lymerix and the Connaught
vaccination [19, 20], and the favorable response to IVIg
therapy in Patient 2.
The management of LNB remains controversial as to the
timing and duration of oral and intravenous antibiotics. The
occurrence of peripheral neuropathy, dysautonomia, and
encephalopathy years later after adequate antibiotic therapy
underscores the selective vulnerability of the nervous system
to the immunological eﬀects of B. burgdorferi infection,
although the exact mechanisms remain uncertain.
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